These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4851580)

  • 21. Physician-pharmacist conflict over drug therapy: a pharmacy policy statement.
    Davis NM
    Hosp Pharm; 1976 Apr; 11(4):134-5. PubMed ID: 1026699
    [No Abstract]   [Full Text] [Related]  

  • 22. Bill may curb physician's right to prescribe.
    Harvey MW; Keller SE
    Leg Aspects Med Pract; 1978 Sep; 6(9):27-30. PubMed ID: 750818
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmacist's role in product selection.
    J Am Pharm Assoc; 1971 Apr; 11(4):181-99. PubMed ID: 5170866
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists.
    Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM
    Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic issues in the antisubstitution controversy.
    Sharpe TR
    Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug therapy assessments by pharmacists.
    McKenney JM; Wyant SL; Atkins D; Davis L; Carasiti ME
    Am J Hosp Pharm; 1980 Jun; 37(6):824-8. PubMed ID: 7395877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equivalent therapy at lower cost. The oral penicillins.
    Kemp BA; Moyer PR
    JAMA; 1974 May; 228(8):1009-14. PubMed ID: 4406336
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacist-acquired medication history.
    Covington TR; Pfeiffer FG
    Am J Hosp Pharm; 1972 Aug; 29(8):692-5. PubMed ID: 5052417
    [No Abstract]   [Full Text] [Related]  

  • 30. Information flows on a drug product selection bill.
    Smith MC
    Am J Pharm Sci Support Public Health; 1978; 150(2):51-8. PubMed ID: 686161
    [No Abstract]   [Full Text] [Related]  

  • 31. In defense of the Drug Research Board.
    Azarnoff DL
    JAMA; 1975 Aug; 233(5):425-6. PubMed ID: 1173852
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: ADR.
    J Ky Med Assoc; 1974 Nov; 72(11):579. PubMed ID: 4455752
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial: States continue to turn thumbs down on pro-substitution legislation.
    J Med Assoc State Ala; 1973 Sep; 43(3):149-50. PubMed ID: 4752432
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidelines for pharmacists performing product selection.
    Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394
    [No Abstract]   [Full Text] [Related]  

  • 35. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(3):26-30. PubMed ID: 4546224
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacist-physician partnership reduces unwanted drug consequences.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):9-10, 12. PubMed ID: 13677339
    [No Abstract]   [Full Text] [Related]  

  • 39. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 40. Joint statement on antisubstitution laws and regulations.
    JAMA; 1973 Jul; 225(2):142. PubMed ID: 4740275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.